David C Yeomans Selected Research

1- (N- (2- methoxybenzyl)acetylamino)- 3- (1H- indol- 3- yl)- 2- (N- (2- (4- (piperidin- 1- yl)piperidin- 1- yl)acetyl)amino)propane (Lanepitant)

10/2012	Preprotachykinin-A gene disruption attenuates nociceptive sensitivity after opioid administration and incision by peripheral and spinal mechanisms in mice.
10/2009	Role of substance P signaling in enhanced nociceptive sensitization and local cytokine production after incision.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David C Yeomans Research Topics

Disease

39	Pain (Aches) 10/2021 - 10/2002
19	Hyperalgesia 04/2018 - 10/2002
10	Inflammation (Inflammations) 11/2017 - 06/2006
7	Chronic Pain 07/2021 - 10/2002
6	Neuralgia (Stump Neuralgia) 08/2017 - 01/2004
6	Postoperative Pain 08/2017 - 02/2008
6	Hypersensitivity (Allergy) 01/2017 - 01/2012
4	Migraine Disorders (Migraine) 05/2022 - 09/2016
4	Wounds and Injuries (Trauma) 12/2010 - 10/2007
3	Traumatic Brain Injuries (Traumatic Brain Injury) 11/2017 - 11/2014
3	Surgical Wound 12/2010 - 06/2006
3	Edema (Dropsy) 10/2010 - 06/2006
3	Infections 06/2005 - 10/2002
2	Acute Pain 01/2021 - 01/2013
2	Diabetic Neuropathies (Diabetic Neuropathy) 01/2017 - 06/2004
2	Fibromyalgia (Fibrositis) 01/2014 - 01/2013
2	Back Pain (Backache) 03/2010 - 10/2009
2	Herpes Simplex 02/2008 - 03/2006
2	Pancreatitis 02/2008 - 10/2007
1	Mental Disorders (Mental Disorder) 10/2021
1	Brain Concussion (Cerebral Concussion) 04/2018
1	Hemorrhage 06/2017
1	Headache (Headaches) 05/2017
1	Shock 05/2017
1	Neuroma 01/2017
1	Brain Injuries (Brain Injury) 01/2017
1	Neuroinflammatory Diseases 01/2017
1	Primary Headache Disorders 09/2016
1	Headache Disorders (Headache Syndromes) 09/2016

Drug/Important Bio-Agent (IBA)

11	CytokinesIBA 01/2013 - 06/2006
8	Analgesics (Analgesic Drugs)IBA 07/2021 - 01/2004
8	Opioid Analgesics (Opioids)IBA 08/2017 - 01/2004
7	Oxytocin (Pitocin)FDA LinkGeneric 05/2022 - 01/2017
6	Biomarkers (Surrogate Marker)IBA 01/2017 - 12/2008
5	Capsaicin (Zostrix)FDA Link 01/2013 - 10/2002
5	EnkephalinsIBA 03/2008 - 10/2002
4	Oxytocin Receptors (Oxytocin Receptor)IBA 05/2022 - 09/2016
4	Pharmaceutical PreparationsIBA 05/2017 - 03/2011
4	preproenkephalinIBA 01/2017 - 01/2004
4	Interleukin-6 (Interleukin 6)IBA 01/2013 - 10/2009
4	Morphine (MS Contin)FDA LinkGeneric 10/2012 - 10/2007
4	Complementary DNA (cDNA)IBA 02/2008 - 10/2002
3	Peptides (Polypeptides)IBA 07/2021 - 01/2004
3	NeuropeptidesIBA 01/2017 - 10/2002
3	Transcription Factors (Transcription Factor)IBA 01/2017 - 02/2014
3	Buprenorphine (Subutex)FDA LinkGeneric 01/2016 - 03/2011
3	Formaldehyde (Formol)FDA Link 06/2011 - 05/2004
2	Neurotransmitter Agents (Neurotransmitter)IBA 07/2021 - 01/2021
2	PolymersIBA 07/2021 - 01/2012
2	Hormones (Hormone)IBA 01/2021 - 01/2017
2	Protein Isoforms (Isoforms)IBA 01/2021 - 12/2013
2	salicylhydroxamic acid (SHAM)IBA 04/2018 - 06/2017
2	Complement System Proteins (Complement)IBA 01/2018 - 06/2006
2	Sodium Channels (Sodium Channel)IBA 08/2017 - 12/2013
2	Calcitonin Gene-Related PeptideIBA 01/2017 - 09/2016
2	Early Growth Response Protein 1IBA 01/2017 - 02/2014
2	Local AnestheticsIBA 01/2017 - 12/2010
2	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 01/2017
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2017 - 11/2014
2	EnzymesIBA 01/2017 - 09/2016
2	ImmunosorbentsIBA 01/2017 - 09/2016
2	Proteins (Proteins, Gene)FDA Link 09/2016 - 07/2010
2	1- (N- (2- methoxybenzyl)acetylamino)- 3- (1H- indol- 3- yl)- 2- (N- (2- (4- (piperidin- 1- yl)piperidin- 1- yl)acetyl)amino)propane (Lanepitant)IBA 10/2012 - 10/2009
2	Substance PIBA 12/2010 - 10/2009
2	Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA 10/2010 - 10/2010
2	Nerve Growth Factor (NGF)IBA 10/2009 - 08/2008
2	Opiate AlkaloidsIBA 02/2008 - 02/2004
2	beta-Galactosidase (Lactaid)IBA 02/2008 - 10/2007
2	proenkephalinIBA 10/2007 - 01/2004
1	MagnesiumIBA 05/2022
1	PlasticsIBA 07/2021
1	Voltage-Gated Sodium ChannelsIBA 01/2021
1	SaxitoxinIBA 01/2021
1	AcidsIBA 11/2017
1	LipidsIBA 11/2017
1	lysophosphatidic acidIBA 11/2017
1	Monoclonal AntibodiesIBA 11/2017
1	Histone Acetyltransferases (Histone Acetyltransferase)IBA 06/2017
1	Histones (Histone)IBA 06/2017
1	Histone Deacetylases (Histone Deacetylase)IBA 06/2017
1	Nitroglycerin (Dynamite)FDA LinkGeneric 05/2017
1	Sigma-1 ReceptorIBA 01/2017
1	Chemokine ReceptorsIBA 01/2017
1	Kruppel-Like Transcription Factors (Kruppel-Like Factors)IBA 01/2017
1	OligonucleotidesIBA 01/2017
1	RacivirIBA 01/2017
1	LigandsIBA 01/2017
1	2- hydroxy- N,N- dimethyl- 3- (2- ((1- (5- methylfuran- 2- yl)propyl)amino)- 3,4- dioxocyclobut- 1- enylamino)benzamideIBA 01/2017
1	Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA 01/2017
1	carprofen FDA Link 01/2016
1	Meloxicam (Mobic)FDA LinkGeneric 01/2016
1	Anesthetics (Anesthetic Agents)IBA 11/2014
1	SR-ATIBA 03/2014

Therapy/Procedure

10	Analgesia 07/2021 - 05/2004
8	Therapeutics 07/2021 - 10/2002
3	Intranasal Administration 05/2022 - 04/2018
2	Spinal Injections 02/2014 - 01/2004
2	Transcranial Magnetic Stimulation 01/2014 - 01/2013
1	Anesthesia 08/2017
1	Ligation 01/2017